Pharmafile Logo

Digital Therapeutics Landscape in Europe

September 3, 2020 |  

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

Digital Therapeutics Landscape in Europe: The Case of Germany and the UK

The COVID-19 virus crisis has opened immense windows of opportunity in healthcare around the globe. One of the greatest opportunities is in digital health, and in particular, digital therapeutics (DTx). The need for continued medical care combined with social distancing has led to a spike in use of digital health tools worldwide.1 As the interest in and use of digital health has grown during this period, we anticipate that investments in digital health tools will continue to accelerate after the COVID-19 pandemic. When the COVID-19 outbreak started, millions of Chinese people turned to online doctors and online health tools1 to find the needed support for their health. While these developments could create new risks for privacy and data protection, they also represent an unprecedented opportunity to integrate industry 4.0 in healthcare for the benefit of patients.

HIGHLIGHTS INCLUDE:
  • Opportunities and threats of digital therapeutics after COVID-19
  • Digital therapeutics landscape in the European Union
  • Review and comparison of the German and UK therapeutics landscape
  • Develop game-changing insights and competitive advantage on both a global and local scalepi

Pink divider

Download the white paper and learn how it’s happening now!

Download the Paper- PMLiVE

  1. https://www.cnbc.com/2020/03/26/investments-in-digital-health-care-could-accelerate-after-coronavirus-credit-suisse-says.html

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Digital Therapeutics Landscape in Europe

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

OPEN Health’s virtual reflections on the World Orphan Drug Congress US

Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...

A day in the life of the Global Head of Publications

We asked Mina Patel to give us an insight into her role as Global Head of Publications at OPEN Health

Striving to become more patient-centric?

Explore more with OPEN Health

Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:Advanced Therapies Commercial: Tuesday, August 25Succeeding with Star Wars...

OPEN Health at the World Orphan Drug Conference USA

Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !

OPEN Health Medical Communications is awarded Medical Affairs Agency of The Year at the Communiqué Awards 2020

We are delighted to announce that OPEN Health Medical Communications was named Medical Affairs Agency of the Year at the virtual 2020 Communiqué Awards ceremony on 02 July 2020.

Candice Subero to Lead Global Marketing for OPEN Health

OPEN Health is pleased to announce that Candice Subero has been named Global Marketing Lead, effective June 4, 2020. Candice will oversee strategic communications and marketing efforts across all OPEN...

The RARE Youth Revolution has begun

OPEN Health are proud to support RARE Revolution Magazine who have launched a dedicated RARE youth online platform powering up the voices of the youth rare disease community.